SCHEMBL19620732

SCHEMBL19620732

NC1=C(OS(=O)Cc2ccccc2)C(=O)C(c2ccco2)O1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
RUNX1 Q01196 1/20 0.33
CBFB Q13951 1/20 0.33
KDM4E B2RXH2 3/20 0.33
POLB P06746 3/20 0.33
MAPT P10636 3/20 0.33
ALDH1A1 P00352 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
APEX1 P27695 1/20 0.32
ADORA2B P29275 1/20 0.32
FPR1 P21462 1/20 0.32
GAA P10253 1/20 0.32
PKM P14618 1/20 0.31
ADORA1 P30542 1/20 0.31
GSK3B P49841 1/20 0.31
EPHX2 P34913 1/20 0.31
ADORA2A P29274 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19620621 0.84 MAPT (0.49) KMT2AKDM4EPOLBMAPTALDH1A1
SCHEMBL19620630 0.79 HCRTR1 (0.37) POLBALDH1A1
SCHEMBL15627599 0.79 KDM4E (0.41) MEN1KMT2AKDM4EPOLBMAPT
SCHEMBL19620692 0.79 DPP4 (0.38) KDM4EPOLBMAPTEPHX2
SCHEMBL19620539 0.79 CYP1A2 (0.33) KDM4EPOLBMAPTALDH1A1EPHX2
SCHEMBL20367974 0.79 MAPT (0.41) MEN1KMT2AKDM4EPOLBMAPT
SCHEMBL19620541 0.78 KDM4E (0.37) KDM4EPOLBMAPTEPHX2
SCHEMBL19620538 0.78 KDM4E (0.37) KDM4EPOLBMAPTEPHX2
SCHEMBL19620575 0.77 POLB (0.36) MEN1KMT2ARUNX1CBFBKDM4E
SCHEMBL19620531 0.77 MAPT (0.39) KDM4EPOLBMAPTALDH1A1FPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed